# Temozolomide in Treating Women With Advanced Breast Cancer

> **NCT00005054** · PHASE2 · UNKNOWN · sponsor: **The Christie NHS Foundation Trust**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00005054
- **Lead sponsor:** The Christie NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005054, "Temozolomide in Treating Women With Advanced Breast Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00005054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*